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Abstract
Objective: The technical evolution of endografts for the interventional management of infrarenal abdominal aortic
aneurysms (AAA) has allowed a continuous expansion of indications. This study compares the established Talent endograft
with its successor, the Endurant endograft, taking individual aortoiliac anatomy into account.
Methods: From June 2007 to December 2010, 35 patients with AAA were treated with a Talent endograft (33 men) and 36
patients with an Endurant endograft (34 men). Aortoiliac anatomy was evaluated in detail using preinterventional
computed tomography angiography. The 30-day outcome of both groups were compared regarding technical and clinical
success as well as complications including endoleaks.
Results: The Endurant group included more patients with unfavorable anatomy (kinking of pelvic arteries, p=0.017; shorter
proximal neck, p=0.084). Primary technical success was 91.4% in the Talent group and 100% in the Endurant group
(p=0.115). Type 1 endoleaks occurred in 5.7% of patients in the Talent group and in 2.8% of those in the Endurant group
(p=0.614). Type 3 endoleaks only occurred in the Talent group (2.9% of patients; p=0.493). Type 2 endoleaks were
significantly less common in the Endurant group than in the Talent group (8.3% versus 28.6%; p=0.035). Rates of major and
minor complications were not significantly different between both groups. Primary clinical success was significantly better
in the Endurant group (97.2%) than in the Talent group (80.0%) (p=0.028).
Conclusion: Endurant endografts appear to have better technical and clinical outcome in patients with difficult aortoiliac
anatomy, significantly reducing the occurrence of type 2 endoleaks.
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Introduction
Endovascular aneurysm repair (EVAR) has become the method
of choice for treating infrarenal abdominal aortic aneurysms
(AAA). This is largely due to its minimal invasiveness and the
continuously improved outcome with low morbidity and mortality
[1,2]. In addition to aortoiliac anatomy, the material of which
a stent-graft is made and the endograft design are other important
factors contributing to outcome after EVAR [3,4,5,6]. A great
variety of different models and manufacturers are currently
available. They differ in basic design, the endograft material used,
the site of proximal fixation, and the presence of anchoring hooks
or pins at the proximal graft end.
The development of new endografts aims at effectively and
permanently reducing pressure within the aneurysm sac.
Thereby, reinterventions due to a persistent or recurrent
perfusion of the aneurysm are prevented. Moreover, improved
stent-grafts can also be used for EVAR in patients with difficult
aortoiliac anatomies such as short proximal necks, severely
angulated infrarenal aortas, and kinking or heavy calcification of
pelvic arteries [4,7,8].
A fairly new model of endografts is the Endurant endograft,
which evolved from its predecessor, the Talent endograft (both
manufactured by Medtronic Vascular, Santa Rosa, USA).
Optimizing the physical and mechanical properties of both,
the endograft itself and the delivery system has further increased
the range of indications compared with its predecessor [7,9,10].
This has been accomplished by forming sinusoidal M-shaped
main body stents for greater radial force and flexibility as well
as reducing the diameter of the hydrophilic coated delivery
system.
In the present study interventional and postinterventional
outcomes of the Talent and Endurant stent-grafts were compared.
A specific parameter of interest was the individual anatomy of the
aortoiliac vascular system of the patients treated.
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Patients
The institutional review board (the Ethics Committee of the
University of Greifswald) approved this retrospective study
(Approval No. BB 128/11), which complied with the principles
of the Declaration of Helsinki (2008 version). All patients gave
written informed consent to participate.
From June 2007 to December 2010, 72 patients with AAA were
treated with an infrarenal Talent or Endurant endograft. Inclusion
criteria for this retrospective study were elective or emergency
endovascular repair of an AAA using a Talent or Endurant stent-
graft. Patients were excluded if their preinterventional and
postinterventional files (at least up to 30 days after the
intervention) were incomplete or if adequate pre-or postinterven-
tional computed tomography angiography (CTA) or digital
subtraction angiography datasets were not available. One of the
72 consecutive patients was excluded because no adequate
postinterventional CTA was available.
Hence, 71 patients were finally included in the study, 35 in the
Talent group (49.3%) and 36 (50.7%) in the Endurant group.
Sixty-seven patients were male (94.4%), four were female (5.6%).
The mean age of all patients was 7667 years. Basic data did not
differ significantly between the two groups. The data are
summarized in Table 1.
Preinterventional Diagnostic Evaluation
All patients underwent contrast-enhanced CTA before in-
tervention (LightSpeed, 8 rows, GE Healthcare, Munich,
Germany). CTA was performed with 5-mm slice thickness, a pitch
of 1.35:1, and 1.25-mm collimation. The contrast agent (Imeron
350, BRACCO Imaging, Constance, Germany) was administered
intravenously at a dose of 100–120 ml and a flow of 4 ml/s using
bolus tracking. The standard procedure included subsequent axial
reconstruction at 1.25-mm slice thickness, followed by coronal and
sagittal reformation. These images were used to plan EVAR,
which was performed within two weeks of CTA. The recon-
structed axial image series were analyzed using the OsiriX image
viewer (version 3.9.2, Pixmeo Sarl, Bernex, Switzerland). The
following parameters were determined to assess the aortoiliac
anatomy:
1) Length and maximum diameter of the proximal neck.
2) Length and maximum diameter (including mural thrombus)
of the aneurysm sac.
3) Angles between the suprarenal aortic axis and the axis of the
proximal neck (suprarenal angle) and between the proximal
neck and body of the aneurysm (infrarenal angle).
4) Angle between the axes of the common iliac arteries
(bifurcation angle).
5) Tortuosity index expressed as the ratio of the actual length
of the common iliac artery down to the mid-common
femoral artery (puncture site) over the direct distance from
end to end.
6) Evaluation for kinking of the common/external iliac artery
(right-or acute-angled course of the vessel) and aneurysm
extension to at least one common iliac artery.
7) Smallest arterial diameter at the site of ilio-femoral access.
All angles and distances were measured orthogonal to or along
the vascular axis, using double oblique multiplanar reformations
when needed. Vascular diameters were measured from inner wall
to inner wall (perfused lumen).
Choice of Stent-Graft and Intervention
All interventions were performed under aseptic conditions using
the same angiography system (Axiom-Artis, Siemens, Erlangen,
Germany) by a multidisciplinary team including interventional
radiologists and vascular surgeons, each having at least 5 years of
experience in endovascular treatment of AAA. Talent endografts
were used until February 2009, Endurant grafts thereafter.
The contrast agent used was Imeron 300 (BRACCO Imaging,
Constance, Germany). All interventions were performed under
general anesthesia, using bilateral open inguinal surgical access to
the common femoral artery according with the manufacturer’s
instructions. Most electively treated patients received bifurcated
endografts, while aortomonoiliac endografts were used in all
patients undergoing emergency treatment for AAA. In addition,
a crossover bypass graft was carried out in these patients during
the same session. Following EVAR all patients were transferred to
the intensive care unit.
Follow-up
The follow-up period was 30 days. Before discharge from the
hospital, all patients underwent clinical examinations, laboratory
tests (creatinine, urea, hemoglobin, blood count), and CTA (same
CT scanner and technical parameters as for the preinterventional
examinations). In addition, a venous phase series was acquired 45–
60 sec after contrast medium injection. Postinterventional CTA
was performed within 3–30 days of endograft implantation.
Definitions
The definitions below are in accordance with the recommenda-
tions of the Ad Hoc Committee for Standardized Reporting
Practices in Vascular Surgery of the Society for Vascular Surgery
[11].
Primary technical success required the successful introduction
and deployment of the device in the absence of surgical conversion
or mortality, type I or III endoleaks, or graft limb obstruction
without an unplanned endovascular or surgical procedure.
Assisted primary technical success was defined as the need for
additional endovascular or surgical procedures to achieve the
above-mentioned aims.
Primary clinical success required successful deployment of the
endovascular device at the intended location without death as
a result of aneurysm-related treatment, type I or III endoleak, graft
infection or thrombosis, aneurysm expansion or rupture, or




N (range or %)
Endurant N=36
Mean or
N (range or %) p
Age [years] 7568 (58–91) 7866 (68–90) 0.109
Men 33 (94.3) 34 (94.4) 1.000
Hypertension 27 (77.1) 30 (83.3) 0.721
Obesity 6 (17.1) 4 (11.1) 0.514
Hyperlipidemia 15 (42.9) 19 (52.8) 0.549
Smoking 26 (74.3) 27 (75.0) 0.877
Renal insufficiency 8 (22.9) 6 (16.7) 0.721
PAOD 14 (40.0) 17 (47.2) 0.708
PAOD Peripheral artery occlusive disease.
doi:10.1371/journal.pone.0038468.t001
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secondary surgical or endovascular procedure.
Assisted primary clinical success was to achieve the above-
mentioned goals with the use of an additional or secondary
endovascular procedure.
The classification of endoleaks is summarized in Table 2.
Complications were categorized as minor or major. Minor
complications were all undesired events that not required surgical
treatment, recovered spontaneously or within 24 hours (e.g.
hematoma at access site, pneumonia treated with oral antibiotics).
Major complications were defined as those that required an
invasive treatment or led to hospitalisation .24 h (e.g. limb
occlusion treated by surgical intervention).
Statistical Analysis
Statistical analysis was performed using MedCalc (version
11.5.1.0, Mariakerke, Belgium).
Quantitative measurements were expressed as mean 6 standard
deviation. Categorical data were tested using the x
2 test or Fisher’s
exact test. Continuous data were analyzed with the Mann-
Whitney U-test. Statistical significance was assumed at p,0.05.
Results
Aortoiliac Anatomy
The proximal neck had a mean length of 3.9660.19 cm in the
Talent group and was on average 0.75 cm shorter in the Endurant
group (3.2161.35 cm, p=0.084). The suprarenal and infrarenal
angles were not significantly different between the two groups
(p=0.828 and 0.836) (Table 3). Kinking of the common/external
iliac artery was present in 41.7% (15/36) of patients in the
Endurant group, which was significantly more common than in
the Talent group with 14.3% (5/35; p=0.017). The maximum
aneurysm diameter was significantly smaller in the Talent group
compared with the Endurant group (5.2861.50 cm versus
5.8961.59; p=0.037).
Intervention-related Data
The interventions were elective in 91.4% (32/35) of the patients
in the Talent group and in 91.7% (33/36) of the patients in the
Endurant group; three patients in each group were treated for
retroperitoneally ruptured AAA (p=1.000).
In the Talent group, the stent-graft system could be introduced
and the graft deployed as planned in 97.1% (34/35) of the
patients. In one patient, the guidewire perforated the external iliac
artery, requiring an iliacofemoral bypass through which the main
stent-graft body could be introduced.
In the Endurant group, the endograft was delivered as planned
in 100.0% (36/36) of the patients (p=1.000).
The duration of the procedure (biiliac stent-grafts) was
124.0616.7 min in the Talent group and 115624.7 min in the
Endurant group; the difference was not statistically significant
(p=0.146).
The primary technical success rate was 91.4% (32/35) in the
Talent group. Reasons for technical failure were perforation of the
external iliac artery in the patient already mentioned. In one
patient a small type 1a endoleak was detected immediately after
the intervention (proximal neck length: 0.12 cm) and persisted
despite repeated balloon dilatation. However, no reintervention
was performed within the follow-up period. One patient had
a dissection of the external iliac artery occurring during in-
troduction of the main stent-graft body. In this patient, subsequent
percutaneous transluminal angioplasty (PTA) with stent implan-
tation in the same session resulted in assisted primary technical
success (Table 4).
In the Endurant group, primary technical success was achieved
in 100% (36/36; p=0.115).
Endoleaks
Type 1 primary endoleaks occurred in 5.7% (2/35) of the
patients of the Talent group. As already mentionezd, one type 1a
endoleak occured during the implantation procedure. Another
type 1a endoleak was detected at follow-up and was successfully
treated by proximal stent-graft extension. Further follow-up
revealed a patient with a type 3a endoleak (at the intermodular
connection site of the contralateral limb and the main body),
which was treated by implantation of another covered stent-graft.
In the Endurant group, follow-up detected one type 1a endoleak
(2.8%) which could be adequately treated by embolization using
coils and histoacryl.
In the Talent group, 28.6% of the patients (10/35) had type 2
endoleaks, including 8 type 2a endoleaks and 2 type 2b endoleaks
(Fig. 1). One type 2a endoleak occurred in a patient who also had
a type 1 endoleak. In the Endurant group, only 8.3% (3/36) type 2
endoleaks (all type 2a) occured. This was significantly less than in
the Talent group (p=0.035) (Fig. 2). So far, no reinterventions
were required for type 2 endoleaks in either group.
Other Major and Minor Complications
No patient died within 30 days of the intervention. In the Talent
group, there was one graft limb occlusion (5th postinterventional
day). The patient was successfully treated by open surgical
thrombectomy. A second patient with stenosis of the iliac limb
(detected 7 days after the intervention) successfully underwent
PTA with stenting. In the Endurant group, one patient had
a myocardial infarction and required intensive care treatment,
which markedly prolonged the hospital stay. Mesenteric ischemia,
stroke, or heavy blood loss due to the intervention (.1000 ml) did
Table 2. Classification of endoleaks*.
Type of endoleak Cause of perigraft flow
I a) Inadequate seal at proximal end of endograft b) Inadequate seal at distal end of endograft c) Inadequate seal at iliac
occluder plug
II Flow from visceral vessel (lumbar, mesenteric inferior, hypogastric artery) a) Single vessel (simple) b) At least two vessels
creating a circuit (complex)
III Flow from module disconnection
IV Flow from porous fabric (,30 days after graft placement)
*modified according to [11].
doi:10.1371/journal.pone.0038468.t002
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(1/35) in the Talent group and 2.8% (1/36) in the Endurant
group; the difference was not significant (p=1.000) (Table 5). The
minor complication rate was 5.7% (2/35) and 11.1% (4/36)
respectively; again the difference was not statistically significant
(p=0.647).
Endovascular reinterventions were performed in 8.9% (3/35) of
the patients of the Talent group and in 2.8% (1/36) of the patients
of the Endurant group (p=0.375).
The median intensive care unit stay was 1 day (range, 0–32)
for all patients. The median total hospital stay was 6 days (range,
2–36).
The primary clinical success rate after 30 days was 80.0% (28/
35) in the Talent group and 97.2% (35/36) in the Endurant group
(p=0.028).
Discussion
The continuous improvement of available endografts and
delivery systems has increased the indications for EVAR in
patients with AAA [7,12,13]. The broader spectrum of indications
using state-of-the-art stent-grafts is particularly beneficial for
patients with difficult aortoiliac anatomy. This includes short
proximal necks (,1 cm), severe supra- and infrarenal aortic
angulation or elongation and kinking of pelvic arteries [6,7,9]. To
better fit these anatomical variants the Endurant endograft has
been developed.
In this study, we compared the established Talent endograft
with its successor, the Endurant endograft.
Comparison of baseline data shows that more patients with
difficult anatomy have been treated using an Endurant endograft.
Kinking of the common/external iliac artery was significantly
more common in the Endurant group (41.7 versus 14.3%;
Table 3. Morphologic criteria for evaluating aortoiliac anatomy.
Morphologic criteria
Talent N=35 Mean or
N (range or %)
Endurant N=36 Mean or
N (range or %) p
Length of proximal neck [cm]
proximal neck ,1.5 cm
3.9660.19 (0.92–6.91) 5 (14.3%) 3.2161.35 (0.45–5.86) 5 (13.9) 0.084 1.000
Diameter of proximal neck [cm] 2.4760.32 (1.86–3.33) 2.5060.42 (1.88–3.59) 0.902
Suprerenal angle [u] 13.6612.6 (1.0–58.2) 14.6614.5 (2.1–57.6) 0.828
Infrarenal angle [u] 33.0615.3 (1.3–73.2) 37.6617.3 (7.4–86.2) 0.836
Maximum diameter of aneurysm sac [cm] 5.2861.50 (3.21–9.45) 5.8961.59 (2.65–10.68) 0.037
Length of aneurysm sac [cm] 7.7162.94 (1.14–14.8) 8.0363.46 (2.67–16.8) 0.818
Bifurcation angle [u] 48.6624.5 (12.3–120.5) 52.1628.6 (4.5–122.2) 0.633
Aneurysm extension to common iliac artery 6 (17.1) 4 (11.1) 0.514
Kinking of common/external iliac artery 5 (14.3) 15 (41.7) 0.017
Tortuosity index, right 1.2860.24 (1.00–1.96) 1.2260.21 (1.00–1.86) 0.373
Tortuosity index, left 1.2660.26 (1.04–2.24) 1.2660.27 (1.00–2.25) 0.713
Tortuosity index, side from which main endograft body was introduced 1.2760.23 (1.00–1.96) 1.2660.22 (1.00–1.86) 0.486
Minimum diameter at access site, right [cm] 0.6160.14 (0.33–0.92) 0.6760.20 (0.23–1.36) 0.119
Minimum diameter at access site, left [cm] 0.6560.14 (0.39–0.93) 0.6760.19 (0.35–1.19) 0.904
Minimum diameter, side from which main endograft body was
introduced [cm]
0.6260.14 (0.39–0.93) 0.6760.21 (0.23–1.36) 0.294
doi:10.1371/journal.pone.0038468.t003
Table 4. Intervention-related data of the Talent and Endurant groups.
Intervention-related data
Talent N=35 Mean or
N (range or %)
Endurant N=36 Mean or
N (range or %) p
Elective intervention 32 (91.4) 33 (91.7) 1.000
Biiliac endograft 28 (80.0%) 33 (91.7%) 0.189
Duration of intervention, biiliac graft [min] 124.0616.7 (90.0–164.0) 115.0624.7 (41.0–162.0) 0.146
Duration of intervention, monoiliac graft [min] 131.0634.8 (74.0–168.0) 116.0647.8 (32.0–169.0) 0.689
Primary technical success 32 (91.4) 36 (100.0) 0.115
Assisted primary technical success 33 (94.3) 36 (100.0) 0.239
Primary endoleak
type 1 2 (5.7) 1 (2.8) 0.614
type 2 10 (28.6) 3 (8.3) 0.035
type 3 1 (2.9) 0 0.493
doi:10.1371/journal.pone.0038468.t004
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the Endurant group, but the difference falls short of statistical
significance (p=0.084). The primary technical success rate was
slightly lower in the Talent group compared with the Endurant
group (91.4% versus 100%; p=0.115). These results are in
agreement with data reported in the literature with rates of 91–
99% for Talent endografts and 98–100% for Endurant endografts
[7,9,14,15,16]. Another incentive for designing new stent-grafts is
to minimize the need for secondary interventions to maintain graft
function. Endoleaks, stent dislocation and limb occlusion are the
three most important reasons for reinterventions. A leak can result
in reperfusion of the aneurysm sac and is associated with an
increased risk of aneurysm rupture [15,16,17,18]. In this study, the
rates of primary type 1 endoleaks were not significantly different
between the Talent (5.7%) and Endurant (2.8%) group (p=0.614).
A trend towards slightly higher incidences of type 1 endoleaks for
Talent versus Endurant endografts has also been reported in the
literature (8–12% versus 0–6%, depending on the underlying
aneurysm anatomy) [4,7,15,19]. The better results for Endurant
endografts might be attributable to the changed design of the
proximal end of the suprarenal stent, which has an additional set
of 6 paired anchor pins. Also, additional M stents are now
Figure 1. CTA of a large infrarenal AAA in a 79-year-old patient. A, Volume reconstruction (VR) of CTA with moderate calcification within the
aneurysm sac and both common iliac arteries. B, VR performed 12 days after implantation of a Talent stent graft. C, Venous phase CTA reveals a type
2 endoleak (asterisk) posterior of the stent graft limb and a perfused lumbar artery on the left (arrow). D, More inferiorly, the site of entry of the
lumbar artery into the aneurysm sac is seen (arrow).
doi:10.1371/journal.pone.0038468.g001
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and sealing.
Type 3 endoleaks were only observed in one patient of the
Talent group (2.9%, p=0.493); this type of endoleak is rare with
both models of endografts [4,15]. In contrast, type 2 endoleaks are
much more common with their incidence ranging from 6% to
30%, depending on the type of endograft used [2,3,7]. In the
present study, type 2 endoleaks were significantly more common in
the Talent group (28.6% versus 8.3% in the Endurant group;
p=0.035). The occurrence of type 2 endoleaks with different
endograft systems was also investigated by Sheehan et al., who also
found only slight differences between the systems [3]. They
attributed the differences to different endograft designs including
their different mechanical properties. The more flexible structure
of Endurant endografts might improve their alignment to the
aortic wall and/or the mural thrombus, sealing the remaining
arterial branches e.g. lumbar arteries or the inferior mesenteric
artery, which may otherwise relevantly perfuse the aneurysm sac.
Thus, these branches might be occluded by the endograft,
preventing a type 2 endoleak. Although type 2 endoleak is still
quite common, there is an ongoing controversy regarding its
clinical relevance with regard to aneurysm growth or rupture
Figure 2. CTA of an infrarenal AAA in a 74-year-old patient. A, VR of the long aneurysm with a short proximal neck. The aneurysm involves
the aortic bifurcation, and there is marked angulation of the infrarenal portion (arrow indicates the left renal artery). Both common iliac arteries are
markedly elongated. B, Lateral VR more clearly showing the elongation of the left common iliac artery and also severe kinking (arrowhead) at its
origin as well as marked infrarenal angulation of the proximal neck (arrow indicates the left renal artery). C, Postinterventional VR indicating
successful implantation of an Endurant stent graft and exclusion of AAA (arrow indicates the left renal artery).
doi:10.1371/journal.pone.0038468.g002
Table 5. Outcome at 30-day follow-up in the Talent versus Endurant group.
30-day outcome Talent N=35 N (%) Endurant N=36 N (%) p
Mortality 0 0 1.000
Major complications
Occlusion of iliac limb 1 (2.9)
* 0 0.493
Myocardial infarction 0 1 (2.8)
* 1.000
Total 1 (2.9) 1 (2.8) 1.000
Minor complications
Hematoma at access site 1 (2.9) 2 (5.6) 1.000
Stenosis of iliac limb 1 (2.9) 0 0.493
Renal infarction 0 1 (2.8)
{ 1.000
Pneumonia 0 1 (2.8) 1.000
Total 2 (5.7) 4 (11.1) 0.674
Endovascular reintervention 3 (8.6) 1 (2.8) 0.357
Primary clinical success 28 (80.0) 35 (97.2) 0.028
Assisted primary clinical success 32 (91.4) 35 (97.2) 0.357
*Classified as clinical failure.
{ Small embolic renal infarction at lower pole after the intervention without clinically relevant impairment of renal function.
doi:10.1371/journal.pone.0038468.t005
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Treatment of persisting type 2 endoleaks is mandatory because
prolonged blood inflow into the aneurysm sac will significantly
increase pressure within the aneurysm sac, which may reach levels
of up to 70–80% of systemic blood pressure [20,21,22]. In this
study population, there have not been any reinterventions for type
2 endoleaks so far. However, this may be due to the short follow-
up period. Another limitation is the small number of patients
included, which is due to the single-center design. Other
limitations include the lack of randomization, the retrospective
design as well as the inclusion of both elective and emergency
procedures. Moreover, a learning curve has to be taken into
account, as the two endograft systems were used successively, and
the interventionalists’ earlier experience with the Talent endograft
has probably improved their handling of the Endurant grafts and
may have reduced complications.
Major and minor complications did not differ significantly
between the two groups (p=1.000 and 0.647, respectively). No
compression of the iliac limb with subsequent thrombosis was
observed, which was a common complication described after
Endurant procedures by Makaroun et al. [4]. As a possible cause
the authors discussed the greater flexibility of the Endurant graft,
which, while improving navigation, increases the risk of collapse of
the stent-graft lumen. Yet, in the present study the Endurant group
showed a significantly better result in terms of primary clinical
success (97.2% versus 80.0% for Talent; p=0.028).
To avoid the above limitations and to confirm these results
randomized multicenter studies in larger patient populations
including their long-term follow-up are required.
In conclusion, this results suggests that Endurant endografts
have a better outcome with a significantly lower rate of type 2
endoleaks compared to Talent endografts despite a higher pro-
portion of patients with difficult aortoiliac anatomy in the
Endurant group.
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